JCOVDEN
-
JCOVDEN™ (COVID-19 Vaccine (Ad26.COV2-S [recombinant])) is indicated for active immunization for the prevention of coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 virus in individuals 18 years of age and older. JCOVDEN must be injected intramuscularly only. Drug Identification Number (DIN): 02513153.
- Vaccine Access
- Medical Information Responses
- COVID-19 Vaccine Clinical Trials
- General Information on COVID-19 Vaccines
- Johnson & Johnson Press Releases
- National Advisory Committee on Immunization (NACI) Recommendations
- Cannot find what you are looking for?
- JCOVDEN Vaccine Medication InformationJCOVDEN Vaccine Medication Information
For more information, please download:
Product Monograph (PDF) August 5, 2022 Patient Medication Information (PDF) August 5, 2022 Health Product Risk Communication - Labeling (PDF) April 26, 2021 Health Product Risk Communication - Safety (PDF) April 26, 2021 Health Product Risk Communication (PDF) March 5, 2021 Storage, Expiry, Dosing and Administration Guide (PDF) November 2, 2021 Public Advisory - Safety (PDF) November 9, 2021 Health Product Risk Communication - Labeling (PDF) November 18, 2021 Canadian Reference Label